Piramal Pharma Limited
FDA inspection history in Navi Mumbai, India, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Navi Mumbai, India.
Cited most
Across all Piramal Pharma Limited observations on file
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.192Production record review1
- 21 CFR 211.198Complaint files1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Piramal Pharma Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Navi Mumbai, India
One Form 483 · 2025 · 5 observations
Latest: Form 483, Feb 17, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-02-17 | 483 Form 483 | Navi Mumbai, India | 5 | $99 |
Investigators on these documents
FEI number 3008763768 · most recent document Feb 17, 2025
About Piramal Pharma Limited
How many FDA Form 483s has Piramal Pharma Limited received?
FDA Intel has 1 Form 483 on file for Piramal Pharma Limited; the most recent is dated Feb 17, 2025.
When was Piramal Pharma Limited last inspected by FDA?
The most recent FDA inspection document on file for Piramal Pharma Limited is a Form 483 dated Feb 17, 2025, for the site in Navi Mumbai, India.
What did FDA cite at Piramal Pharma Limited?
The regulations cited most in the observations on file for Piramal Pharma Limited are 21 CFR 211.186 (Master production and control records), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.198 (Complaint files), 1 time.